Tumor Microenvironment-Responsive Cu/CaCO3 -Based Nanoregulator for Mitochondrial Homeostasis Disruption-Enhanced

Yajie Zhao1,2, Yulong Bian1,2, Xiao Xiao1,2

  • 1State Key Laboratory of Rare Earth Resource Utilization, Changchun Institute of Applied Chemistry, Chinese Academy of Sciences, Changchun, 130022, P. R. China.

Insights

Intelligent nanoparticles deliver oxygen and ions to tumor sites, enhancing cancer therapy by generating reactive oxygen species (ROS) through chemodynamic and sonodynamic approaches.

Area of Science:

  • Biomedical Engineering
  • Nanotechnology
  • Cancer Therapy

Background:

  • Tumor microenvironment (TME) characteristics like high glutathione (GSH) and hypoxia limit reactive oxygen species (ROS) cancer therapy.
  • Existing therapies struggle with insufficient hydrogen peroxide (H2O2) levels in the TME.

Purpose of the Study:

  • To develop TME-responsive nanoparticles for enhanced ROS-mediated cancer therapy.
  • To overcome limitations of GSH, hypoxia, and low H2O2 in the TME.

Main Methods:

  • Fabrication of intelligent copper-dropped calcium carbonate loading sonosensitizer Ce6 nanoparticles (Cu/CaCO3@Ce6, CCC NPs).
  • Utilizing CCC NPs for TME-responsive self-supply of oxygen.
  • Employing Ca2+ and Cu2+ release for enhanced chemodynamic therapy (CDT) and sonodynamic therapy (SDT).

Main Results:

  • CCC NPs release Ca2+, Cu2+, and Ce6 in the TME, consuming GSH and generating hydroxyl radicals via Fenton-like reactions.
  • Ultrasound irradiation amplifies oxidative stress through singlet oxygen release (SDT).
  • Ca2+ influx disrupts mitochondria, further increasing oxidative stress.

Conclusions:

  • The developed CCC NPs effectively address TME limitations for ROS-cancer therapy.
  • Ca2+-overloading-strengthened CDT/SDT offers a promising strategy for cancer treatment.
  • Cu-dropped CaCO3-based nanoregulators represent a new paradigm in ROS-contributed cancer therapy.

Related Concept Videos

The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.8K
Drugs that Destabilize Microtubules01:10

Drugs that Destabilize Microtubules

Microtubules are dynamic structures and can be regulated by microtubule targeting agents (MTAs). Microtubule destabilizing drugs are a class of MTAs that destabilize and prevent microtubules' polymerization. Both natural and synthetic chemicals can be found under this class of drugs. Vincristine and vinblastine, two vinca alkaloids, and colchicine were among the first to be discovered. These drugs can affect cells in various ways, either by inducing a change in cell morphology, preventing...
2.0K
Drugs that Stabilize Microtubules01:15

Drugs that Stabilize Microtubules

Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.1K
Electron Transport Chain: Complex I and II01:46

Electron Transport Chain: Complex I and II

The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
14.9K